ARTICLE | Clinical News
ARG201 regulatory update
December 22, 2008 8:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for ARG201 to treat systemic sclerosis. arGentis has completed a Phase II trial of the ...